Blood platelet biochemistry.

Defects in platelet function or formation increase the risk for bleeding or thrombosis, which indicates the crucial role for platelets in maintaining haemostasis in normal life. Upon vascular injury, platelets instantly adhere to the exposed extracellular matrix which results in platelet activation and aggregation and the formation a haemostatic plug that stops bleeding. To prevent excessive platelet aggregate formation that eventually would occlude the vessels, this self-amplifying process nevertheless requires a tight control. This review intends to give a comprehensive overview of the currently established main mechanisms in platelet function.

[1]  I. Landrieu,et al.  The Talin Rod IBS2 α-Helix Interacts with the β3 Integrin Cytoplasmic Tail Membrane-proximal Helix by Establishing Charge Complementary Salt Bridges* , 2008, Journal of Biological Chemistry.

[2]  M. Hoylaerts,et al.  von Willebrand factor binds to native collagen VI primarily via its A1 domain. , 1997, The Biochemical journal.

[3]  S. Shurin,et al.  A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans , 2009, Nature Medicine.

[4]  R. Bobe,et al.  How many Ca2+ATPase isoforms are expressed in a cell type? A growing family of membrane proteins illustrated by studies in platelets , 2005, Platelets.

[5]  M. Moroi,et al.  Signal-transducing Mechanisms Involved in Activation of the Platelet Collagen Receptor Integrin α2β1 * , 2000, The Journal of Biological Chemistry.

[6]  M. Leslie.  Cell biology. Beyond clotting: the powers of platelets. , 2010, Science.

[7]  B. Nieswandt,et al.  Glycoprotein VI but not α2β1 integrin is essential for platelet interaction with collagen , 2001 .

[8]  S. Neelamegham,et al.  hydrodynamic shear: effect on shear-induced platelet activation under α von Willebrand factor self-association on platelet GpIb , 2013 .

[9]  S. Moncada,et al.  An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Deckmyn,et al.  von Willebrand factor to the rescue. , 2009, Blood.

[11]  P. Lenting,et al.  The von Willebrand factor self‐association is modulated by a multiple domain interaction , 2005, Journal of thrombosis and haemostasis : JTH.

[12]  Hong Chen,et al.  Reciprocal Signaling by Integrin and Nonintegrin Receptors during Collagen Activation of Platelets , 2003, Molecular and Cellular Biology.

[13]  S. Israels,et al.  Platelet dense granules: structure, function and implications for haemostasis. , 1999, Thrombosis research.

[14]  Stefan Offermanns,et al.  Activation of Platelet Function Through G Protein–Coupled Receptors Platelets As Immune Cells: Bridging Inflammation and Cardiovascular Disease In Vivo Thrombus Formation Platelet Adhesion Platelet Inhibitors and Thrombus Formation , 2006 .

[15]  Z. Ruggeri,et al.  Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib , 2010, Thrombosis and Haemostasis.

[16]  A. Marcus,et al.  Heterologous cell–cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase‐1) , 2003, Journal of thrombosis and haemostasis : JTH.

[17]  S. Kunapuli,et al.  Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways. , 2010, The Biochemical journal.

[18]  R. Farndale,et al.  Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. , 1999, Cardiovascular research.

[19]  P. Carmeliet,et al.  Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization , 2010, Journal of thrombosis and haemostasis : JTH.

[20]  W. Ouwehand,et al.  Structural Basis for the Platelet-Collagen Interaction , 2007, Journal of Biological Chemistry.

[21]  U. Walter,et al.  cGMP and cGMP-dependent protein kinase in platelets and blood cells. , 2009, Handbook of experimental pharmacology.

[22]  M. Wilm,et al.  IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. , 2007, Blood.

[23]  B. Nieswandt,et al.  Calcium signaling in platelets , 2009, Journal of thrombosis and haemostasis : JTH.

[24]  M. Moroi,et al.  Platelet glycoprotein VI: its structure and function. , 2004, Thrombosis research.

[25]  Richard W. Farndale,et al.  Structural Basis of Collagen Recognition by Integrin α2β1 , 2000, Cell.

[26]  A. Aszódi,et al.  The vasodilator‐stimulated phosphoprotein (VASP) is involved in cGMP‐ and cAMP‐mediated inhibition of agonist‐induced platelet aggregation, but is dispensable for smooth muscle function , 1999, The EMBO journal.

[27]  J. Sadler,et al.  Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. So,et al.  Inducible COX-2 dominates over COX-1 in prostacyclin biosynthesis: mechanisms of COX-2 inhibitor risk to heart disease. , 2011, Life sciences.

[29]  M. Hoylaerts,et al.  Activation of αIIbβ3 is a sufficient but also an imperative prerequisite for activation of α2β1 on platelets , 2007 .

[30]  Sriram Neelamegham,et al.  von Willebrand factor self-association on platelet GpIbalpha under hydrodynamic shear: effect on shear-induced platelet activation. , 2010, Blood.

[31]  D. Wagner,et al.  The role of platelet adhesion receptor GPIbα far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis , 2006, Proceedings of the National Academy of Sciences.

[32]  U. Walter,et al.  Actin-based motility: stop and go with Ena/VASP proteins. , 2001, Trends in biochemical sciences.

[33]  G. R. Van de Walle,et al.  Two Functional Active Conformations of the Integrin α2β1, Depending on Activation Condition and Cell Type* , 2005, Journal of Biological Chemistry.

[34]  M. Moroi,et al.  Platelet glycoprotein VI. , 2008, Advances in experimental medicine and biology.

[35]  P. Siljander,et al.  Collagen-platelet interactions: recognition and signalling. , 2003, Biochemical Society symposium.

[36]  C. Gleissner,et al.  Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. , 2010, Blood.

[37]  M. J. Fisher,et al.  p38 Mitogen-activated Protein Kinase Phosphorylates Cytosolic Phospholipase A2 (cPLA2) in Thrombin-stimulated Platelets , 1996, The Journal of Biological Chemistry.

[38]  Xiaoping Du.  Signaling and regulation of the platelet glycoprotein Ib–IX–V complex , 2007, Current opinion in hematology.

[39]  M. Moroi,et al.  Platelet collagen receptor integrin alpha2beta1 activation involves differential participation of ADP-receptor subtypes P2Y1 and P2Y12 but not intracellular calcium change. , 2001, European journal of biochemistry.

[40]  A. Pollitt,et al.  GPVI and CLEC‐2 in hemostasis and vascular integrity , 2010, Journal of thrombosis and haemostasis : JTH.

[41]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition , 2001 .

[42]  W. Ouwehand,et al.  Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. , 2004, Blood.

[43]  L. Cavallini,et al.  Prostacyclin and Sodium Nitroprusside Inhibit the Activity of the Platelet Inositol 1,4,5-Trisphosphate Receptor and Promote Its Phosphorylation (*) , 1996, The Journal of Biological Chemistry.

[44]  G. Reed.  Platelet secretory mechanisms. , 2004, Seminars in thrombosis and hemostasis.

[45]  H. Deckmyn,et al.  Inherited traits affecting platelet function. , 2008, Blood reviews.

[46]  L. Brass,et al.  Signaling through G Proteins in Platelets: to the Integrins and Beyond , 1997, Thrombosis and Haemostasis.

[47]  M. Detmar,et al.  Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skin. , 2010, Blood.

[48]  D. Maynard,et al.  Proteomic analysis of platelet α‐granules using mass spectrometry , 2007 .

[49]  M. Cattaneo.  The Platelet P2 Receptors , 2019, Platelets.

[50]  N. Watanabe,et al.  Reconstructing and Deconstructing Agonist-Induced Activation of Integrin αIIbβ3 , 2006, Current Biology.

[51]  J. Sixma,et al.  Functional self-association of von Willebrand factor during platelet adhesion under flow , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[52]  B. Nieswandt,et al.  Kindlin-3 is essential for integrin activation and platelet aggregation , 2008, Nature Medicine.

[53]  N. Tandon,et al.  GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism. , 2006, Thrombosis research.

[54]  J. Sixma,et al.  A3 Domain Is Essential for Interaction of von Willebrand Factor with Collagen Type III , 1996, Thrombosis and Haemostasis.

[55]  S. Illenberger,et al.  Phosphorylation of the Vasodilator-stimulated Phosphoprotein Regulates Its Interaction with Actin* , 2000, The Journal of Biological Chemistry.

[56]  M. Hollenberg,et al.  Mechanisms of action of proteinase‐activated receptor agonists on human platelets , 2002, British journal of pharmacology.

[57]  S. Nagata,et al.  Calcium-dependent phospholipid scrambling by TMEM16F , 2010, Nature.

[58]  Neil Bate,et al.  The structure of an integrin/talin complex reveals the basis of inside‐out signal transduction , 2009, The EMBO journal.

[59]  W. Bergmeier,et al.  Novel molecules in calcium signaling in platelets , 2009, Journal of thrombosis and haemostasis : JTH.

[60]  K. Naseem,et al.  Nitric oxide inhibits von Willebrand factor‐mediated platelet adhesion and spreading through regulation of integrin αIIbβ3 and myosin light chain , 2009, Journal of thrombosis and haemostasis : JTH.

[61]  J. Freedman,et al.  Inhibition of Platelet Function by the Endothelium , 2019, Platelets.

[62]  Jun Qin,et al.  A Structural Mechanism of Integrin αIIbβ3 “Inside-Out” Activation as Regulated by Its Cytoplasmic Face , 2002, Cell.

[63]  Ann M Graybiel,et al.  Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III. , 2007, The Journal of clinical investigation.

[64]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[65]  S. Kunapuli,et al.  Differential phosphorylation of myosin light chain (Thr)18 and (Ser)19 and functional implications in platelets , 2010, Journal of thrombosis and haemostasis : JTH.

[66]  M. Crúz,et al.  Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibα , 2007, Journal of thrombosis and haemostasis : JTH.

[67]  K. Varughese,et al.  Binding of α-thrombin to surface-anchored platelet glycoprotein Ibα sulfotyrosines through a two-site mechanism involving exosite I , 2011, Proceedings of the National Academy of Sciences.

[68]  A. Graybiel,et al.  CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation , 2004, Nature Medicine.

[69]  Chungho Kim,et al.  The final steps of integrin activation: the end game , 2010, Nature Reviews Molecular Cell Biology.

[70]  P. D. de Groot,et al.  Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. , 2010, Blood.

[71]  P. Lenting,et al.  Shielding of the A1 Domain by the D′D3 Domains of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V* , 2006, Journal of Biological Chemistry.

[72]  J. Whisstock,et al.  Glycoprotein Ib-IX-V. , 2003, The international journal of biochemistry & cell biology.

[73]  P. Smethurst,et al.  Identification of a major GpVI-binding locus in human type III collagen , 2008, Blood.

[74]  J. Freyssinet,et al.  Platelet microparticles and vascular cells interactions: A checkpoint between the haemostatic and thrombotic responses , 2008, Platelets.

[75]  J. Freyssinet,et al.  Formation of procoagulant microparticles and properties. , 2010, Thrombosis research.

[76]  S. Homer-Vanniasinkam,et al.  Nitric oxide specifically inhibits integrin‐mediated platelet adhesion and spreading on collagen , 2008, Journal of thrombosis and haemostasis : JTH.